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Discussion
There is extensive experience with the use of endovascular devices for
closure of intracardiac defects and patent ductus arteriosus. However,
there is little information on the use of these devices for intrapulmonary
occlusions. The CardioSEAL double umbrella device (NMT Medical)
was approved in the United States for closure of muscular ventricular
septal defects in December 2001. Successful use of this device has been
reported in occlusion of a large pulmonary arteriovenous malformation in
an adult patient with hereditary hemorrhagic telangiectasia.1 In our patient
this type of device was used to close an intrapulmonary vein. The
procedure was successful; however, the patient returned 5 years later with
hemoptysis secondary to erosion of the device into the right upper lobe
bronchus. To our knowledge, this is the first reported case of such a
complication. In a recent review of a group of 417 patients who under-
went a device closure of secundum atrial septal defect, Chessa and
associates2 reported an 8.6% incidence of complications. The most com-
mon complication was a device malposition or embolization (3.5%).
Seven patients required surgical intervention after device embolization.
No erosions were reported in this series; however, hemopericardium and
fistula formation have been described after atrial septal defect closure.3,4
The mechanism of erosion is unknown, but it is likely that it is due at least
in part to persistent pressure to the endovascular surface from a con-
strained device. In our case the arms of the CardioSEAL were partially
collapsed in the vascular structure.
The use of stents, coils, and other intravascular devices has grown
dramatically in the last several years. As their use increases, so does
recognition of their limitations and the potential complications of migra-
tion and embolization. Intravascular foreign body migration is a well-
documented phenomenon, particularly for intracardiac missiles and mis-
sile emboli. Previously, foreign body removal was advocated for most
cases; however, a more selective approach has recently been advocated.5
The unstable nature of intravascular foreign bodies continues to be
stressed.
The use of percutaneous interventional techniques for the treatment of
congenital cardiac disease will continue to increase. However, the natural
history of intravascular devices is not well known. Intravascular foreign
objects have a tendency to erode into the surrounding structures and to
migrate. As use of intravascular devices continues to expand, close
follow-up of these patients is necessary.
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Tetralogy of Fallot and hypoplastic aortic arch: A novel perspective
David L. S. Morales, MD, Daniel J. DiBardino, MD, Wesley Vick, MD, Charles D. Fraser, Jr, MD, and
E. Dean McKenzie, MD, Houston, Tex
T e t ralogy of Fallot with coarctation of the aorta is a rarediagnosis that is counterintuitive to widely accepted theo-ries of cardiac embryology. This arrangement of tetralogyof Fallot (TOF) with a left-sided obstructive lesion has
only been reported in the literature in 9 previous patients. 1,2 We
describe a unique variant of this unlikely association (TOF and a
hypoplastic aortic arch) and discuss its possible embryology and
morphogenesis.
Clinical Summary
A 4-month-old child, weighing 7 kg, was diagnosed with TOF at
birth. She was placed on beta-blocker therapy and monitored with
oxygen saturations in the low 90s, despite severe right ventricular
outflow tract (RVOT) obstruction (gradient of 64 mm Hg). Physical
examination revealed the following blood pressures: right arm 83/40
mm Hg, left arm 89/39 mm Hg, and right leg 82/38 mm Hg, and a
slight decrease in lower extremity pulses. A follow-up echocardio-
gram at 3 months revealed a large ascending aorta and a concern for
aortic coarctation. Subsequent cardiac magnetic resonance imaging
demonstrated TOF and a high right aortic arch with tubular hypopla-
sia and a small descending aorta with diastolic runoff (Figure 1). The
narrowest segment (0.25 cm) was the distal arch between the right
common carotid and right subclavian arteries.
At operation, there was an anterior malrotation of the dilated
ascending aorta, a right aortic arch with mirror image branching,
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and a mildly hypoplastic descending aorta, measuring 7 mm. The
distal aortic arch was significantly elongated, and there was an
acute angle of approximately 180°, “a buckling,” within the distal
aortic arch (Figure 2). We could not identify a ductus or ligamen-
tum arteriosus. Intracardiac findings were consistent with TOF
including severe infundibular obstruction.
The patient underwent transatrial repair of TOF, closure of the
patent foramen ovale, and aortic arch advancement. The latter was
accomplished by transection of the isthmus and an end-descending
to side-ascending aortic anastomosis. Postoperative transesopha-
geal echocardiography demonstrated good function, no residual
shunt, and no RVOT obstruction. The patient recovered without
incident and was discharged in 6 days, fully saturated and with no
blood pressure gradient among the extremities.
Discussion
The development of a circulatory system with obstructed pulmonary
and systemic blood flows seems counterintuitive and not compatible
with fetal development. Yet 9 cases of this type have been reported,
beginning in 1967,1 and these cases bring into question the long-held
theories concerning the morphogenesis of aortic and left heart ob-
structive lesions. The well-known hemodynamic molding theory of
Rudolph and associates3 states that aortic coarctation and arch hy-
poplasia develop because of a paucity of blood flow through the aorta
during fetal development. This explanation does not suffice in a
patient with TOF because right-sided obstructive lesions should result
in increased right-to-left blood flow across the foramen ovale and
through the left heart and aorta during fetal development, preventing
aortic coarctation and hypoplasia. In addition, our patient had no
left-sided obstructing lesions proximal to the aortic arch that could
have interfered with arch development. One previously reported ex-
planation is that infiltrating ductal tissue can cause aortic coarctation
when it constricts postnatally.4 This seems implausible in our patient
because there was true hypoplasia of the arch and no ductus or
ligamentum was identified.
Right aortic arches predominate in the reported cases, as does abnor-
mal brachiocephalic branching. These defects and TOF have been clearly
associated with defects in cardiac neural crest cell migration. Neural crest
cells are critical in the normal patterning of aortic arch vessels and aortic
arch development during fetal life. Cardiac neural crest cell migration into
the heart is a key factor in outflow tract septation, and abnormal migration
can result in conotruncal septation defects. Interestingly, experimental
ablation of embryonic neural crest cells produces a phenotype with 2
consistent components: (1) defective development in the RVOT leading
to aortic override and/or ventricular septal defects; and (2) malformation
and abnormal patterning of the aortic arch vessels leading to such defects
as right aortic arches, retroesophageal subclavian arteries, and hypoplastic
aortic arches. Genetic research in this area has used gene knockout
models in mice and zebrafish to effect neural crest cell maturation and
organization, which has resulted in aortic coarctation and RVOT abnor-
malities.5
Previously accepted theories of diminished flow or ductal infiltra-
tion causing aortic coarctation make TOF and aortic arch hypoplasia
an improbable combination. However, the current body of research on
cardiac neural crest cells allows us to envision how these seemingly
Figure 1. Coarctation of aorta. Left: Three-dimensional recon-
struction of aorta from gadolinium contrast-enhanced magnetic
resonance imaging demonstrates narrowing of superior aspect of
aortic arch (arrow). Right: Spin echo image demonstrates ob-
structive ridge at superior aspect of aortic arch (arrow).
Figure 2. Intraoperative picture of hypoplastic arch. AsA, As-
cending aorta; AA, aortic arch; RLN, recurrent laryngeal nerve;
RAIV, retroaortic innominate vein; RCA, right carotid artery.
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 129, Number 6 1449
unrelated defects may be the result of a common mechanism: altered
neural crest cell migration. Further embryonic and genetic experimen-
tation will likely clarify the role of the neural crest cell at the various
levels of cardiac development.
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Novel management strategy for severe cyanosis after Sano modification
of the Norwood procedure
Janet M. Simsic, MD,a Angel Cuadrado, MD,a Paul M. Kirshbom, MD,b Kirk R. Kanter, MD,b
Donna Ramaswamy, MPH, MS,a Martha Clabby, MD,a and Joseph M. Forbess, MD,b* Atlanta, Ga
Sano modification of the Norwood procedure has resultedin a more favorable distribution of systemic, pulmonary,and coronary blood flow. However, frequently thesepatients present with severe cyanosis caused by dynamic
proximal shunt stenosis. The purpose of this review was to eval-
uate a management strategy for severe cyanosis in this patient
population.
Methods
Between September 2003 and September 2004, 22 newborns un-
derwent Sano modification at Children’s Healthcare of Atlanta.
One patient died before hospital discharge and was excluded from
further analysis. Four (19%) of the 21 remaining patients presented
at 53  26 days of age with oxygen saturations of less than 70%.
These 4 patients (group 1) were compared with the remaining 17
(group 2). Management strategy to treat cyanosis in group 1
patients consisted of increasing preload and -blockade. Age-
matched hemodynamic data were evaluated between group 1 be-
fore therapy and group 2; variables before and after therapy in
group 1 were also evaluated.
Results
Sano shunt size was 6 mm (n  3; birth weight, 3 kg) and 5 mm
(n  1; birth weight, 2 kg; group 1) versus a shunt size of 6 mm
(n  13; 4 patients with a birth weight 3 kg; 9 patients with a
birth weight 3 kg) and 5 mm (n  4; birth weight, 3 kg; group
2). Hemodynamic variables before and after therapy in group 1 are
shown in Table 1. In addition, comparison was made between
hemodynamic variables at the time of presentation with cyanosis
group 1 and group 2 at the same age (Table 2).
This management strategy prolonged the timing to bidirectional
Glenn shunt by 70  40 days in group 1. A bidirectional Glenn
shunt was performed at 123  32 days in group 1 (4/4 patients)
versus 133  28 days in group 2 (11/13 patients, P  .6).
Discussion
Secondary to the variable pulmonary and systemic vascular resis-
tance ratio, the net effect of the Norwood procedure with a sys-
temic–pulmonary artery shunt is runoff from the systemic to the
pulmonary bed during diastole, resulting in a low diastolic blood
pressure, a wider pulse pressure, and a change in the pattern of
From Sibley Heart Center Cardiology/Children’s Healthcare of Atlantaa and
the Division of Pediatric Cardiothoracic Surgery, Emory University,b At-
lanta, Ga.
Received for publication Dec 7, 2004; accepted for publication Dec 15,
2004.
Address for reprints: Janet M. Simsic, MD, Sibley Heart Center Cardiology,
52 Executive Park South, Suite 5200, Atlanta, GA 30329 (E-mail:
simsicj@kidsheart.com).
*Present address: University of Texas Southwestern Medical Center, Dal-
las, Tex.
J Thorac Cardiovasc Surg 2005;129:1450-1
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2004.12.009






No. of patients 4 4 1.0
Oxygen saturation (%) 62 9 80 3 .01
Heart rate (beats/min) 151 13 129 9 .03
Respiratory rate (breaths/min) 60 10 50 22 .4
Systolic blood pressure (mm Hg) 90 1 90 12 1.0
Diastolic blood pressure (mm Hg) 44 8 49 13 .5
Mean blood pressure (mm Hg) 60 5 63 11 .5
RVOT proximal gradient (mm Hg) 92 12 58 13 .02
Mean  SD; paired 2-tailed t test. RVOT, Right ventricular outflow tract.
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